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Abstract
Background: FAAH (fatty acid amide hydrolase), primarily expressed in the liver, hydrolyzes the endocannabinoids fatty acid
ethanolamides (FAA). Human FAAH gene mutations are associated with increased body weight and obesity. In our present
study, using targeted metabolite and lipid profiling, and new global acetylome profiling methodologies, we examined the
role of the liver on fuel and energy homeostasis in whole body FAAH
2/2 mice.
Methodology/Principal Findings: FAAH
2/2 mice exhibit altered energy homeostasis demonstrated by decreased oxygen
consumption (Indirect calorimetry). FAAH
2/2 mice are hyperinsulinemic and have adipose, skeletal and hepatic insulin
resistance as indicated by stable isotope phenotyping (SIPHEN). Fed state skeletal muscle and liver triglyceride levels was
increased 2–3 fold, while glycogen was decreased 42% and 57% respectively. Hepatic cholesterol synthesis was decreased
22% in FAAH
2/2 mice. Dysregulated hepatic FAAH
2/2 lysine acetylation was consistent with their metabolite profiling.
Fasted to fed increases in hepatic FAAH
2/2 acetyl-CoA (85%, p,0.01) corresponded to similar increases in citrate levels
(45%). Altered FAAH
2/2 mitochondrial malate dehydrogenase (MDH2) acetylation, which can affect the malate aspartate
shuttle, was consistent with our observation of a 25% decrease in fed malate and aspartate levels. Decreased fasted but not
fed dihydroxyacetone-P and glycerol-3-P levels in FAAH
2/2 mice was consistent with a compensating contribution from
decreased acetylation of fed FAAH
2/2 aldolase B. Fed FAAH
2/2 alcohol dehydrogenase (ADH) acetylation was also
decreased.
Conclusions/Significance: Whole body FAAH deletion contributes to a pre-diabetic phenotype by mechanisms resulting in
impairment of hepatic glucose and lipid metabolism. FAAH
2/2 mice had altered hepatic lysine acetylation, the pattern
sharing similarities with acetylation changes reported with chronic alcohol treatment. Dysregulated hepatic lysine
acetylation seen with impaired FAA hydrolysis could support the liver’s role in fostering the pre-diabetic state, and may
reflect part of the mechanism underlying the hepatic effects of endocannabinoids in alcoholic liver disease mouse models.
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Introduction
Obesity, now recognized as a chronic disease, is the second
leading cause of preventable death. In 2008 the World Health
Organization estimated 1.5 billion adults, 20 and older, were
overweight. Of these over 200 million men and nearly 300 million
women were obese (http://www.who.int/mediacentre/factsheets/
fs311/en/) [1]. It is well established that obesity is a major risk
factor for the development of Type II diabetes (‘diabesity’) [2].
The endogenous cannabinoid system, is comprised of i)
endogenously produced ligands, the endocannabinoids, ii) canna-
binoid receptors and iii) cannabinoid metabolizing enzymes [3],
plays a crucial role in controlling a diversity of physiological and
behavioral processes including those involved in energy homeo-
stasis [4,5,6]. Several studies have shown that the endocannabi-
noid system is dysregulated [7,8,9,10] and activated in peripheral
tissues [11,12,13] during obesity.
The fatty acid amides (FAA), anandamide and 2-arachidonoyl
glycerol (2-AG) are the most widely studied cannabinoid ligands
[14,15,16]. These lipids are present throughout the body and their
levels are finely regulated by the balance between synthesis and
inactivation [17]. FAA hydrolase (FAAH) is the main FAA
degrading enzyme, primarily acting on anandamide (AEA), an
endogenous ligand of CB1 cannabinoid receptors, and oleoyletha-
nolamide (OEA), which binds to peroxisome proliferator-activated
receptors-a to reduce food intake and promote lipolysis [5].
Studies have shown that a missense polymorphism in the FAAH
gene is associated with severe obesity (BMI$40), along with
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acylethanolamines [18,19]. However, the precise role of FAAH in
the regulation of energy expenditure and fuel homeostasis is not
well understood. Tourino et al. showed that on a high-fat diet,
FAAH
2/2 mice had elevated hypothalamic, hepatic and small
intestinal AEA and OEA levels [5]. Despite comparable caloric
intake, these high-fat fed, FAAH
2/2 mice showed obesity and
elevated ad-lib glucose and insulin levels implying dysregulation of
energy storage and/or expenditure [5].
In our present study, the contributions of liver FAAH absence to
the effects of whole body FAAH deletion on fuel and energy
homeostasis was examined utilizing fluxomics, targeted metabolite
and lipid profiling, and in particular, a new global acetylome
profiling method. Stable isotope flux phenotyping revealed that
FAAH
2/2 mice displayed hepatic, skeletal and adipose insulin
resistance. Label-free quantitation of the hepatic acetylome under
different nutritional states, demonstrated that FAAH
2/2 mice
exhibit dysregulated lysine acetylation of enzymes in key metabolic
pathways. The functionality of altered acetylation of specific
proteins was further assessed by metabolite analyses.
Our study suggests that FAAH
2/2 mice are a model of the pre-
diabetic state, having adipose, skeletal and hepatic insulin
resistance, preserved skeletal muscle fuel switching, and unsup-
pressed hepatic glucose production (HGP) with impaired glucose
tolerance. Liver FAAH absence contributes to the pre-diabetic
phenotype of FAAH
2/2 mice by mechanisms, at least in part,
dependent on dysregulated lysine acetylation, resulting in
impairment of hepatic glucose and lipid metabolism.
Results
The Obese Pre-Diabetic Phenotype of FAAH
2/2 Mice
FAAH
2/2 mice on a regular chow were significantly (1.25-fold)
heavier than age matched wild-types (Table 1). Increased body
weight could be attributed, in part, to increased food intake by
FAAH
2/2 mice, which consumed 26% more food/day compared
to wild-types (not different when normalized to body weight).
Body composition analysis revealed that FAAH
2/2 mice had
significantly higher fat mass and lower lean mass (Table 1). After a
15 h overnight fast, FAAH
2/2 mice displayed nearly three-fold
higher basal insulin levels compared to wild-types. Fasting basal
glucose was not different between the two groups. The obesity and
hyperinsulinemia with normal glucose levels observed in FAAH
2/2
mice is similar to that reported in pre-diabetic individuals with
whole body insulin resistance. Both insulin resistance and metabolic
inflexibility have been described as co-incident in obesity [20,21],
therefore we examined metabolic inflexibility and energy expendi-
ture in FAAH
2/2 mice by indirect calorimetry.
FAAH
2/2 Mice are Metabolically Flexible but Exhibit
Decreased Energy Expenditure
To determine the effect of FAAH deletion on energy
expenditure, FAAH
2/2 and wild-type mice were subjected to
indirect calorimetry. Figure 1A (h-h) and 1B (12 h average).
Oxygen consumption (VO2), RER and activity were measured
during the ad-lib state (light/dark cycles) and during a 12 h
overnight fast followed by 5 h of re-feeding. FAAH
2/2 mice
displayed a significant decrease in VO2 during all conditions, even
when normalized to lean body mass (data not shown).
RER was similar between FAAH
2/2 and wild-type mice during
ad-lib dark cycle, and during fasting/re-feeding, implying
preservation of skeletal muscle fuel utilization/flexibility. During
the ad-lib light cycle however, RER was higher in FAAH
2/2 mice
compared to wild-types (Fig. 1A–b). This suggests that FAAH
2/2
mice were eating during this time, consistent with increased food
intake reported above. Ambulatory activity was significantly lower
for the FAAH
2/2 mice during the 5 hr of re-feeding following the
fast (Fig. 1B–c), but was overall similar between FAAH
2/2 and
wild-type mice (Fig. 1A–c).
FAAH
2/2 Mice have Dysregulated Lipid and Glycogen
Levels
Following an 18 h fast hepatic triglyceride (TAG) levels were
similar in FAAH
2/2 and wild-type mice (data not shown). In
contrast, re-fed FAAH
2/2 mice had a 2-fold increase in both
hepatic and skeletal muscle TAGs (TLC, Fig. 2a). The hepatic and
muscle TAGs were also quantified per mg tissue, and given in
Figure S3. Interestingly, fed FAAH
2/2 hepatic and skeletal
muscle glycogen levels were significantly (p,0.05) decreased
compared to wild-types (Fig. 2a). Hepatic de novo lipogenesis was
not different between FAAH
2/2 and wild-type mice, while
cholesterol synthesis was significantly lower in FAAH
2/2 mice
(Fig. 2c). Fasted/fed levels of key metabolic proteins involved in
hepatic fuel switching showed no differences [fatty acid synthase
(FAS), ATP citrate lyase (ACL), glucose-6-phosphate dehydroge-
nase (G6PDH), Rheb, 6-phosphofructo-2kinase (6-PF2K-B),
glucokinase (GCK), AMPK and acetyl-CoA carboxylase (ACC),
Figure S1]. The normal levels of these proteins may reflect the pre-
diabetic state, preserving control of lipogenesis at the expense of
hyperinsulinemia.
Acylcarnitines, prerequisites in the oxidation of fatty acids, were
overall significantly decreased in both fasted and fed FAAH
2/2
livers (Fig. 3a). Despite decreased hepatic acylcarnitines, which
imply increased fatty acid oxidation (FAO), FAAH
2/2 livers
accumulated TAG. Increased TAG accumulation may reflect
increased re-esterification, due to increased adipose lipolysis/
plasma free fatty acids (NEFAs) in the fasted state (see below),
indicated by increased levels of lipin 1 and DGAT 1 in the fed
state (Fig. 2b)
FAAH Deficiency Results in Adipose Tissue Insulin
Resistance
The fasted/re-fed plasma profile is summarized in Figure 4.
18 h fasted FAAH
2/2 mice had significantly higher insulin,
NEFAs, free glycerol and TAG levels compared to wild-type mice.
Elevated lipids, together with high plasma insulin levels, suggest
unsuppressed lipolysis, indicative of adipose tissue insulin resis-
tance.







Body weight 28.7260.64 34.9563.36**
Food intake (gms/day) 3.560.4 4.4160.62*
% Fat Mass 8.860.2 (n=6) 13.761** (n=9)
% Lean Mass 86.660.4 (n=6) 82.261* (n=9)
Basal glucose (15 h fast mg/dl) 14865.1 134613.40
Basal insulin (15 h fast ng/ml) 0.47460.13 1.35160.13**
Data are mean6SEM.
*p,0.05,
**p,0.01 by Student’s t-test for wild-type vs. FAAH
2/2 mice.
doi:10.1371/journal.pone.0033717.t001
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2/2 plasma glucose, insulin and TAGs
were significantly higher compared to wild-type mice. Free
glycerol was lower and NEFAs were not different in FAAH
2/2
mice compared to wild-types. Plasma total cholesterol remained
unchanged during both fasted and re-fed states between the two
groups of mice.
Adipose tissue lipolysis was assessed by measuring glycerol
production using 2-
13C glycerol infusions (Fig. 5). After an 18 h
fast, despite increased insulin levels, FAAH
2/2 mice had a 40%
increase in glycerol production (lipolysis), and a 1.5-fold increase in
hepatic glucose production (HGP) from glycerol compared to wild-
types (Fig. 5A and 5B respectively). Glycerol production and HGP
from glycerol following re-feeding were similar between FAAH
2/
2 and wild-type mice (data not shown). The decreased triose-P
metabolites in the fasted state of FAAH2/2 mice (Table 2) also
support the re-direction of triose-P intermediates to HGP.
FAAH
2/2 Deficiency Results in Hepatic Insulin Resistance
The unsuppressed HGP from glycerol, despite basal hyperin-
sulinemia, seen in FAAH
2/2 mice suggested hepatic insulin
resistance. This was confirmed by measuring HGP during an 18 h
fast using U-
13C glucose infusions (Table 3). Despite 2-fold higher
basal insulin levels in FAAH
2/2 mice, HGP and plasma glucose
levels were comparable to wild-types. FAAH
2/2 livers failed to
suppress HGP, despite elevated plasma insulin. This indicates a
significant degree of hepatic insulin resistance in FAAH
2/2 mice
for these constant glucose infusion conditions. Figure 6 shows
alterations in hepatic TCA cycle and glycolytic intermediates for
the fasted and/or fed states, another manifestation of hepatic
insulin resistance in FAAH
2/2 mice. Fumarate, malate and
aspartate were decreased, and citrate increased, in the fed state of
FAAH
2/2 mice, while in the fasted state, aspartate, citrate,
glycerol-3-P and dihydroxyacetone-P were decreased for FAAH
2/
2 mice, suggesting alterations in the malate-aspartate shuttle, and
glycolysis.
FAAH
2/2 mice have Preserved Peripheral Glucose
Disposal
Figure 7 shows the time course of the change in (a) plasma total
glucose, (b) insulin, and (c) [6, 6-
2H]-glucose during a stable
isotope labeled GTT (SipGTT). Integrative responses are
summarized in the inset table on right. The area under the curve
Figure 1. Indirect calorimetry of FAAH
2/2 and wild-type mice. A) hr-hr B) 12 hr average. a) Oxygen consumption (VO2), b) Respiratory
exchange ratio (RER) and c) Activity during the diurnal cycle and fasted to fed transitions. Day (light cycle) and night (dark cycle) 12 hours, (over) night
fast 215 h, day re-fed 25 h in duration. n=8, data are mean 6 SEM, *p,0.05, **p,0.01 by Student’s t-test.
doi:10.1371/journal.pone.0033717.g001
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2H] curve was not different
between wild-type and FAAH
2/2 mice indicating no change in
dynamic glucose disposal. However, hyperinsulinemia in FAAH
2/2
mice was evident indicated by their AUC for plasma insulin which
was 3 times higher compared to wild-type mice. Total plasma
glucose was elevated in the latter half of the GTT, consistent with
non-suppressible HGP.
Skeletal muscle protein synthesis was significantly decreased in
FAAH
2/2 mice (Fig. 7d), which, along with decreased fed muscle
glycogen stores, is also an indication of skeletal muscle insulin
resistance.
FAAH Deficiency Results in Dysregulation of the Hepatic
Acetylome
The changes from fasted to fed hepatic acetyl-CoA levels were
significant for FAAH
2/2 mice, in contrast to wild-type mice
(Fig. 3b), suggesting an overall increase in acetyl-CoA levels in
response to re-feeding in the absence of FAAH. Dysregulation of
acetyl-CoA levels could affect feedback regulation of the metabolic
acetylome [22], supported here by our analysis of the 18 h fasted/
5 h re-fed hepatic proteome for lysine acetylation. A global
representation of dysregulated lysine acetylation in FAAH
2/2
livers using immunoprecipitation (IP) with an anti-acetylated lysine
antibody followed by western blot analysis is shown in Figure S4a.
Western analysis of the anti-acetylated lysine IP for two important
acetylation target proteins (alcohol and malate dehydrogenase) was
performed to demonstrate differential fasting to re-fed regulation
of acetylation (Fig. S4b). Since all the acetylated sites on proteins
may not even be accessible to the anti-acetylated lysine antibody
for IP, label-free proteomics was performed.
In total we identify and report 217 peptides from 95 proteins
(Table S1). Validated peptides with a common sequence but
modifications at different sites are treated as different entries in the
table. An index number was given to each entry. Multiple
acetylated peptides from the same protein were grouped in the list,
so they have neighboring index numbers. The list of largely altered
acetylated peptides, their sequences, protein origins with their
index values are summarized in Table S2. In total, 49 acetylated
peptides from 12 different proteins that were altered are presented.
Table S3 compares and summarizes the acetylated peptides and
corresponding proteins that showed more than a four-fold change
between 18 h fast/5 h fed FAAH
2/2 and wild-type mice. Figure 8
shows the log10 ratios of the EIC (extracted ion chromatogram)
peak areas of the largely changed peptides, comparing between the
wild-type and FAAH
2/2 groups, as well as their feeding
conditions. Log10 ratio higher than or lower than 0 indicates that
abundance of the acetylated peptide either is increased or
decreased respectively. All signals were normalized to the most
Figure 2. FAAH deficiency affects fuel storage. a. Fed triglycerides and glycogen of liver and skeletal muscle. Upper panel shows thin layer
chromatography (TLC) for hepatic and intra-muscular triglycerides with corresponding densitometry. The lower panel shows the amount of glycogen
in the same tissues. Data are mean 6 SEM, n=4, *p,0.05, **p,0.01, ***p,0.001 FAAH
2/2 vs. wild-type by Student’s t-test. b. Immunoblot analysis
for Lipin 1 and DGAT 1 in overnight fasted (18 h) and 5 h re-fed liver (Top). Quantification normalized by actin content and arbitary units expressed
relative to wild-type (Bottom). n=4, data are mean 6 SEM. *p,0.05, **p,0.01 by Student’s t-test. c. De novo lipogenesis and Cholesterol synthesis.
Synthesis rates measured in fed FAAH
2/2 mice vs. wild-type mice over a 10 day period. Data are mean 6 SEM, n=6, *p,0.05 by Student’s t-test.
doi:10.1371/journal.pone.0033717.g002
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calculated from the average EIC area values from triplicate LC-
MS/MS experiments. For cases where several acetylated peptides
are originated from the same protein sequence, the results were
grouped and shaded with gray background color. The 12 proteins
correspond to these groups of peptides are indicated with single
letters on top of each group. Distribution of the Log10 values for all
the quantified acetylated peptides from FAAH
2/2 vs. wild type
mice observed under fasted and re-fed conditions are illustrated in
Figure S2.
Predominately mitochondrial proteins in addition to glycolytic
enzymes were affected by the fasted/re-fed dysregulation in lysine
acetylation in FAAH
2/2 liver. Fasted FAAH
2/2 showed an
increase in the acetylation of ATP synthase subunit d, and a
decrease in the acetylation of acetyl-CoA acetyltransferase
(ACAT1) and malate dehydrogenase (MDH2) compared to wild-
type mice (Table S3). Fed FAAH
2/2 mice showed an increase in
the acetylation of ATP coupling factor 6 and MDH2, and a
decrease in the acetylation of fructose-bisphosphate aldolase B, 3-
ketoacyl-CoA thiolase and alcohol dehydrogenase compared to
wild-type mice.
Changes in hepatic metabolic flexibility/fuel switching may be
reflected by the differences seen in fasted/re-fed acetylation. The
re-fed versus fasted FAAH
2/2 mice had increases in acetylation
Figure 3. FAAH deficiency affects disposition of hepatic acyl carnitine and acetyl-CoA. a. Hepatic acyl carnitine profile in 18 h fasted and
5 h re-fed mice. Data are mean 6 SEM, n=4 for FAAH
2/2 vs wild-type mice. Non-repeated measures 2-way ANOVA was done to calculate statistical
significance. P,0.001 for both row and columns factors. Bonferroni post-tests showed P,0.001 for FAAH
2/2 acetylcarnitine. b. Hepatic acetyl-CoA
levels in 18 h fasted and 5 h re-fed mice. Data are mean 6 SEM, n=4, **p,0.01 by Student’s t-test for FAAH
2/2 vs wild-type mice.
doi:10.1371/journal.pone.0033717.g003
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contrast, the re-fed versus fasted wild-type mice had increases in
acetylation for ATP synthase subunit d, aspartate aminotransfer-
ase and phosphoglucomutase 2 and decreases in acetylation for
MDH2, ATP synthase-coupling factor 6, and Tiam1.
The significance of changes in acetylation we observed is
emphasized by the metabolite changes measured (Fig. 6). Citrate
which was decreased in fasted FAAH
2/2 mice, increased
significantly upon re-feeding, reflecting changes in acetyl-CoA
levels (Fig. 3b). Mitochondrial MDH2, was hypoacetylated in
fasted FAAH
2/2 livers, and hyperacetylated in fed FAAH
2/2
livers. While fasted fumarate and malate levels were comparable
between the groups, they were significantly decreased in fed
FAAH
2/2 mice consistent with the observed dysregulated MDH2
acetylation. Aspartate aminotransferase (AST), hyperacetylated in
wild-type mice during the re-fed/fasted transition had no change
for FAAH
2/2 mice during such transition. Consistently,
compared to the wild-types, FAAH
2/2 aspartate levels were
decreased in both states supporting altered AST acetylation.
Discussion
FAAH
2/2 mice represent a powerful model system to examine
the central and peripheral consequences of constitutive inactiva-
tion of FAA catabolism [23,24]. FAAs such as AEA play a crucial
role in controlling hunger and development of obesity [25,26].
Weight gain in FAAH
2/2 mice may be secondary to over-eating,
in addition to a direct effect of AEA on adipocyte differentiation
[27,28,29].
In our present study we have examined the metabolic effect of
FAAH gene deletion on fuel switching and energy homeostasis.
Even though liver is the primary insulin sensitive peripheral site for
FAAH expression, SIPHEN assessment concluded that FAAH
deficiency results in whole body insulin resistance, demonstrating a
well defined pre-diabetic phenotype. Using SIPHEN, we recently
established the MKR mouse as a model of Type II DM and
metabolic inflexibility [30]. In this study, we now demonstrate that
the FAAH
2/2 mouse may be an important pre-Type II DM
model. We show that whole body FAAH deletion in mice mimics
several metabolic aspects of pre-diabetes including impaired fuel
utilization, hyperinsulinemia, and hepatic, skeletal muscle and
adipose tissue insulin resistance.
Tourino et al [5], showed that although overall daily food intake
was comparable between FAAH
2/2 and wild-type mice, caloric
intake during dark (,re-fed) and light (,semi-fasted) conditions
were significantly different. In our study, by combining calorim-
etry with metabolic assessments of tissue fuel stores (cholesterol
and fatty acid synthesis, TAG and glycogen levels) after a defined
overnight fast, with or without re-feeding, a more definite
assessment of the effects of FAAH deficiency on overall fuel and
energy homeostasis could be made. Consistent with the ad lib
model of Taurino et al, fed intra-muscular and hepatic TAG levels
were increased in FAAH
2/2 mice compared to wild-types. But
TAG levels (liver and muscle) were normal in the fasted state.
Moreover, observations of decreased fed skeletal muscle and
hepatic glycogen stores, together with decreased skeletal muscle
protein synthesis despite hyperinsulinemia in our study, establish-
es, and is consistent with, skeletal muscle and hepatic insulin
resistance.
Skeletal muscle fuel switching is preserved in FAAH
2/2 mice,
despite increased TAG stores. The preservation of the respiratory
exchange ratio (RER) between fasting and re-feeding (Fig. 1),
implies preservation of skeletal muscle glucose disposal. HGP
equals basal glucose disposal in the fasted state [30,31], and was
Figure 4. FAAH deficiency causes dyslipidemia. Fasted/re-fed plasma glucose and lipid profile for the FAAH
2/2 and wild-type mice. Plasma
samples used were from [U-
13C6] glucose (18 h fast) and [2-
13C] glycerol (5 h re-feed) tracer infusion experiments. n=5, data are mean 6 SEM.
**p,0.01, ***p,0.001 FAAH
2/2 vs. wild-type (fasted) and a p,0.05, b p,0.01, FAAH
2/2 vs. wild-type (fed) by Student’s t-test.
doi:10.1371/journal.pone.0033717.g004
Dysregulated Hepatic Acetylation in FAAH
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2/2 and wild-type mice. This is
probably due, in part, to hyperinsulinemia, preserving skeletal
muscle metabolic flexibility at the cost of insulin resistance. The
liver is insulin resistant to the extent that only lipogenesis
is preserved, as fed glycogen is decreased, and basal HGP is
unsuppressed. As shown in Fig. 7c, [6,6-
2H] glucose disposal is
preserved, but plasma glucose levels are elevated in the latter half
of the GTT, suggesting increased post-prandial HGP. Hyperin-
sulinemia is severe enough that secondary adipose insulin
resistance occurs, as evidenced by an increased rate of basal
lipolysis (Fig. 5).
Metabolomic profiling studies indicated that FAAH
2/2 dele-
tion resulted in overall depletion of hepatic acylcarnitine pools
(Fig. 3a). While this reflects increased fatty acid oxidation,
lipogenesis chronically is not increased. TAG accumulation in
FAAH
2/2 liver is a result of increased re-esterification of plasma
free fatty acids coming from the unsuppressed adipose lipolysis in
Figure 5. FAAH deficiency causes hepatic and adipose insulin resistance. Glycerol production, and hepatic glucose production from
glycerol, assessed using a [2-
13C] glycerol infusion administered by Alza miniosmotic pump. Glycerol production represents mainly in vivo lipolysis,
and was measured after 18 h of overnight fast. Fasted plasma glucose and insulin levels are given in the table. Glycerol production rate is expressed
in terms of mg produced/kg of body weight/minute. n=5, data are mean 6 SEM. *p,0.05, ***p,0.001 wild-type vs. FAAH
2/2 mice by Student’s t-
test.
doi:10.1371/journal.pone.0033717.g005
Table 2. Fasted/Re-fed hepatic triose-p metabolites profile.
nano moles/mg











Glycerol 3 po4 6.23560.31 4.37560.63* 6.80161.11 4.60660.93
Glyceraldehyde-3-P 0.24660.08 0.17160.07 0.19160.03 0.17060.03
Dihdroxyacetone-P 1.59660.07 1.10660.16* 1.82760.34 1.16760.23
Values are data6SEM,
*p,0.05, FAAH
2/2 vs. wild-type mice by Student’s t-test.
doi:10.1371/journal.pone.0033717.t002
Table 3. Plasma glucose and insulin during [U-
13C6] glucose






Plasma glucose (mg/dl) 18663.5 17862.7
Plasma insulin (ng/ml) 0.7960.02 1.8360.02***
Hepatic Glucose Production (mg/kg/min) 38.565.5 31.662.84
Clearance (ml/min) 20.863.2 17.7861.7
Data are mean 6 SEM.
***P,0.001, wild-type vs. FAAH
2/2 mice by Student’s t-test.
doi:10.1371/journal.pone.0033717.t003
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fed state.
More specifically, the liver acyl-carnitine profiling detailed a
decrease in fasted acetyl carnitine, suggesting a decrease of acetyl-
CoA, as acetyl-CoA is buffered via conversion to acetyl carnitine
[32]. This is supported by acetyl-CoA measurements, which show
an increase in acetyl-CoA from the fasted to re-fed state for
FAAH
2/2 mice, as opposed to the wild-type mice (Fig. 3b).
Decreased fasted and increased fed citrate levels in FAAH
2/2
versus wild-type livers support the increased fed production of
acetyl-CoA.
Feedback modulation of the metabolic network is heavily
influenced by acetylation, which serves, in part, as a monitor of
acetyl-CoA levels. Approximately 2000 acetylated proteins have
been previously identified in mammalian cells [33] and prokary-
otic cells [34] and metabolic enzymes are highly represented. It
has been postulated, that acetylation serves to coordinate flux in
the central metabolism network, as nearly all enzymes involved in
glycolysis, gluconeogenesis, the TCA cycle, FAO, the urea cycle,
glycogen metabolism, oxidative phosphorylation, and amino acid
metabolism are acetylated [22,35,36]. Therefore, we investigated
the impact of FAAH deficiency on the hepatic metabolic
acetylome. We compared mitochondrial and cytosolic protein
acetylation changes, to metabolite profiling changes seen in
glycolytic, pentose and TCA cycle, as well as how it relates to
Figure 7. FAAH deficiency causes skeletal muscle insulin resistance. Glucose disposal measured during the Stable isotope Glucose Tolerance
Test (SipGTT) for chow fed, overnight fasted, FAA
H2/2 vs. wild-type mice. Time courses of plasma glucose (a), insulin (b) and [6, 6-2H2]-glucose (c)
normalized to wild-type basal levels are shown (Left). Each point shown represents the mean 6 SEM, n=5. Integrated responses for the areas under
the curve (AUC) are presented in the table shown (Top right). *p,0.05, **p,0.01 for (FAA
H2/2 vs. wild-type). Muscle (quadriceps) protein synthesis in
FAA
H2/2 and wild-type mice (Bottom right) (d). Protein synthesis is represented as % newly made alanine made over the entire 10 day study. Data are
mean 6 SEM. *p,0.05, comparing n=6 for wild-type and FAA
H2/2 mice by Student’s t-test.
doi:10.1371/journal.pone.0033717.g007
Figure 6. FAAH deficiency causes fasted/re-fed dysregulation
of hepatic TCA intermediates. Hepatic TCA intermediates in 18 h
fasted and 5 h re-fed mice. Data are mean 6 SEM, n=4, *p,0.05,
**p,0.01, ***p,0.001 by Student’s t-test in FAAH
2/2 mice vs. wild-type
mice respectively.
doi:10.1371/journal.pone.0033717.g006
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processes, such as HGP, lipogenesis and cholesterol synthesis.
FAAH
2/2 livers had decreased ACAT1 acetylation in the
fasted state. A decrease in 3-ketoacyl-CoA thiolase/trifunctional
protein acetylation was observed in fed FAAH
2/2 livers (Fig. 8).
Both of these enzymes affect the balance between acetyl-CoA and
acetoacetyl-CoA levels, supported by the changes seen in acetyl-
CoA levels (Fig. 3b).
Hydroxymethylglutaryl-coenzyme A (HMG-CoA), the precur-
sor for cholesterol synthesis is formed from the condensation of
acetyl-CoA and acetoacetyl CoA. The decrease in cholesterol
synthesis seen in FAAH
2/2 mice may be reflective of a
disturbance in acetyl-CoA levels arising from the imbalance in
ACAT1 and 3-ketoacyl-CoA thiolase acetylation states. Hepatic
metabolite profiling illustrates the functional importance of
dysregulated lysine acetylation on flux through the TCA and
glycolytic pathways. It also suggests linkages to dysregulation in
hepatic FAO and cholesterol synthesis.
Acetylation of mitochondrial MDH2 can increase its activity
[22,33]. Acetylation of aldolase B can decrease its activity [37,38].
Altered MDH2 activity has potential effects on hepatic energy
homeostasis for (dys)regulation of the malate aspartate shuttle, and
the TCA cycle [39]. The changes in acetylation for mitochondrial
MDH2, which was hypoacetylated in fasted FAAH
2/2 livers, and
hyperacetylated in fed FAAH
2/2 livers supports the metabolite
profiling indicating an impairment in the malate/aspartate shuttle.
While DHAP and glycerol-3-P levels were decreased in the fasted
state of the FAAH
2/2 mice, they were preserved in the fed state,
consistent with a compensating contribution from a decrease in fed
aldolase B acetylation in FAAH
2/2 mice.
In the fed state, under normal conditions, HGP is suppressed by
insulin, and carbohydrate is used as a predominant energy source.
We hypothesize that the hepatic insulin resistance (unsuppressed
glucose production and impaired fuel switching) seen in the pre-
diabetic FAAH
2/2 mouse can be attributed, in part, to its
dysregulated lysine acetylation. In our study, acetylation status of
different proteins differed greatly, as for example, fructose
bisphosphate aldolase B (gluconeogenic) and mitochondrial 3
keto-acyl thiolase (fatty acid oxidizing) enzymes were hypoacety-
lated, and ATP synthase coupling factor 6 and malate dehydro-
genase (mitochondrial) were hyperacetylated, in the fed FAAH
2/2
versus wild-type livers (Figure 8 and Table S3). Acetylation
changes associated with fasted to fed transitions in wild-type versus
FAAH
2/2 mice differed greatly. The observation of these mixed
Figure 8. FAAH deficiency causes dyregulates the hepatic acetylome. Log10 ratios of the fasted and re-fed, wild-type and FAAH
2/2 liver
acetylated peptides. The top 5% dramatically changed acetylated peptides are marked with red *. Acetylated peptides from the same proteins are
grouped and shaded with gray background color. The 12 proteins are indicated with single letters on top of each group of peptides in the figure and
their names are as follows: A. Superoxide dismutase; B. Aspartate aminotransferase; C. T-lymphoma invasion and metastasis-inducing protein 1; D.
ATP synthase coupling factor 6; E. Fructose-bisphosphate aldolase B; F. Acetyl-CoA acetyltransferase; G. GTP:AMP phosphotransferase mitochondrial;
H. 3-ketoacyl-CoA thiolase; I. ATP synthase D chain; J. Phosphoglycerate mutase 2; K. Malate dehydrogenase; L. Alcohol dehydrogenase.
doi:10.1371/journal.pone.0033717.g008
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cellular pools and sub-pools of liver mitochondrial acetyl-CoA and
N-acetyl transferases [40] with hepatic extra-mitochondrial acetyl-
CoA accounting for less than 5% of the total pool. Further, Zhang
et al [41] have shown that sub pools of acetyl-CoA, derived from
different sources, can stream past each other. Their work implies
that competition between drugs being acetylated alters the labeling
of individual acetyl-CoA sub-pools, and it may be competition
between proteins being acetylated also affects acetylation, in
addition to acetyl-CoA compartmentation. While acetylation of
MDH2 and ATP synthase subunit d changed in opposite
directions, acetylation changes for phosphoglycerate mutase 2
and aspartate aminotransferase observed in wild-type mice were
not evident for FAAH
2/2 mice. These changes may be reflected
in the differences seen for malate, aspartate and glycolytic
intermediates. The differences in acetylation for ACAT1 seen in
the fasted to fed transition for FAAH
2/2 mice, not seen for wild-
type, may be reflected in the differences seen in the rate of
cholesterol synthesis. The decreased acetylation of alcohol
dehydrogenase in fed FAAH
2/2 mice, suggests that elevated
hepatic endocannabinoids could alter alcohol metabolism, de-
pending on dietary state.
In conclusion, our study suggests that FAAH
2/2 mice are a
model of the pre-diabetic state, having adipose, skeletal and
hepatic insulin resistances. While fuel switching in skeletal muscle
is preserved, HGP is unsuppressed with impaired glucose
tolerance. Collectively, we propose that dysregulation of lysine
acetylation occurs with impaired FAA metabolism and could
support the liver’s role in fostering the pre-diabetic state seen with
impaired FAA hydrolysis. FAAH deficiency also promotes insulin
resistance and liver steatogenesis, two key steps in the pathogenesis
of non-alcoholic fatty liver disease, and CB1 antagonists have been
proposed in the management of NASH [42]. Elevated liver
endocannaboids have been implicated also in the pathogenesis of
alcoholic liver disease [43,44]. Our FAAH
2/2 hepatic acetylome
findings share similarities with the global ALD acetylome found by
Shepard and Tuma [45], which also found acetylation dysregu-
lation of 3-ketoacyl-CoA thiolase, acetyl-CoA acetyltransferase,
fructose-bisphosphate aldolase B, superoxide dismutase and a
change in ATP synthase, but in subunit b. Also inhibitors of
FAAH are currently in development for the treatment of pain and
inflammation [46], making the characterization of the effects of
FAAH inhibition of further clinical interest. Further work will
establish the linkage between FAAs and disorders of lysine




All animal studies were performed under approved institutional
protocols and according to guidelines established in the Guide for
the Care and Use of Laboratory Animals. The animal protocols
were in accordance with IACUC (Institutional Animal Care and
Use Committee) - Albert Einstein College of Medicine of Yeshiva
University approval # 20090308 and State University of New
York, Stony Brook approval # 1346.
Animals. FAAH
2/2 mice backcrossed at least 6 generations
onto a C57BL/6 background were a generous gift from Dr.
Benjamin F Cravatt (Scripps Research Institute, La Jolla, CA).
Consistent with our previously published work [47,48], and that of
others [49], age matched C57BL/6 mice were used as wild-type
controls. All animals were males, 4–5 months of age, and fed
standard laboratory chow diet (4.5% fat, 20% protein and 54.8%
carbohydrate by weight) (PICOLab Rodent Diet 20; 5053).
Animals were maintained under 12 h light/dark conditions
(0700 h/1900 h) for all studies.
Animals from calorimetry experiments (n=8) were used for
body composition analyses and sacrificed at the end of the D2O
lipogenesis experiments. Five animals each from stable isotope
glucose tolerance test (n=10) were finally sacrificed with Alzet
osmotic minipump SIPHEN studies. Livers from the 18 h fast
n=4/5 h re-fed experiment n=4 without tracer were used for
hepatic metabolite profiling, immunoblot, glycogen, lipid TLC,
acetyl-CoA, acetyl carnitine and acetylome analyses.
Body Composition
Body composition was determined by low resolution nuclear
magnetic resonance (NMR) using a benchtop pulsed NMR (7 T)
system (Minispec Model mq7.5 (7.5 mHz) manufactured and
tested by Bruker Instruments) at Vanderbilt mouse phenotyping
centre. Percent lean mass and fat mass were calculated as a
proportion of body weight. FAAH
2/2 mice and age matched
wild-type C57BL/6 mice were examined.
Indirect Calorimetry
Measurements of oxygen consumption (VO2) and respiratory
quotient (RER) were performed using an Oxymax indirect
calorimetry system (Columbus Instruments, Columbus, OH).
Mice (n=8/genotype) were housed individually in the chamber
for 48 h with lights on from 0700 to 1900 h at an ambient
temperature of 22–24uC. Food was available ad libitum during the
dark cycle (feeding phase 1900–0700 h) and the light cycle (fasting
phase 0700–1900 h). Gas exchange measurements were made
under Oxymax system settings as follows: air flow, 0.6 l/min;
sample flow, 0.5 l/min; settling time, 6 min; and measuring time,
3 min. Ambulatory activity was determined simultaneously using
an Opto-Varimetrix-3 sensor system. Consecutive adjacent
infrared beam breaks in either the x-o ry-axes were scored as an
activity count.
De novo lipogenesis, cholesterol synthesis and protein
synthesis
Lipogenesis, cholesterol and protein synthesis were measured
using deuterated water [
2H2O], tracing the enrichment of
deuterium in palmitate, cholesterol and alanine respectively.
Briefly, mice received an intraperitoneal injection of deuterated
water (
2H2O, at a concentration of 4% lean body mass) containing
0.9% sodium chloride. Mice received 4%
2H2O as drinking water
and were left on 4%
2H2O for 10 days with free access to chow.
Mice were sacrificed at the end of tenth day following a 4 h fast
(0700–1100 h). Blood was collected from the retro-orbital sinus,
liver and skeletal muscle (quadriceps) were removed and snap
frozen in liquid nitrogen. Plasma was used for measuring body
deuterium enrichment.
Palmitate and cholesterol were analyzed as their trimethylsilyl
derivatives using gas chromatography (GC) -electron impact
ionization mass spectrometry (MS) as previously described
[50,51,52,53].
For protein synthesis studies, alanine enrichment was measured
and protein synthesis rate was calculated as previously described
[54,55].
Stable Isotope Flux Phenotyping (SIPHEN)
SIPHEN studies included assessment of hepatic glucose
production ([U-
13C6]-glucose), glycerol production ([2-
13C2]-
glycerol) using Alzet mini-osmotic pumps and a (SipGTT) stable
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stable isotopes were purchased from Cambridge Isotope Labora-
tories (Andover, MA) and were pyrogen tested. Blood samples
were analyzed on a GC/MS. Details can be found in our previous
studies [30,31,56,57,58,59,60].
Serum Analysis
Plasma glucose levels were determined by COBAS MIRA
analyzer (Roche, Montclair, NJ) using the Glucose UV Reagent
(catalog no. 80017, Raichem, San Diego, CA). Plasma insulin was
determined using an ultra-sensitive rat/mouse Insulin ELISA Kit
with intra-assay precision CV#10.0% and 0.1–6.4 ng/ml limit
detection (Crystal Chem. Inc., Cat# 90060). NEFA (WAKO HR
Series NEFA-HR (2) Kit, cat # 997-76491), cholesterol (WAKO
Cholesterol E kit cat # 439-17501) and TG levels (Triglycerides
Reagent kit from Thermo scientific cat # TR22203/2750-500)
were used to determine plasma NEFA, cholesterol and TG levels
respectively.
Acetyl-CoA and Acylcarnitine measurements
Hepatic acetyl-CoA in the fasted and re-fed liver samples was
measured according to [61]. Briefly, frozen pulverized liver
samples were homogenized in phosphate buffered saline
(pH 7.2) and were acidified to 0.1% formic acid. After
centrifugation to get rid of cell debris and proteins, the supernatent
was collected and pH was adjusted to 7.5 with 2–3 drops 50%
ammonium hydroxide and taken for LC/MS analysis.
Hepatic acylcarnitines in fasted and re-fed liver samples were
determined using LC tandem MS as described previously [62]
with slight modifications for sample preparation. Briefly pulverized
liver samples were extracted in 1:1:3 (water:methanol:acetonitrile)
acidified to 0.1% formic acid. Supernatent from spun down
samples were lypophilized, redissolved in 0.1% formic acid,
filtered and used for LC/MS analysis. LC/MS analysis was
performed in a Waters Acquity UPLC system attached to a Xevo
Triple Quadrupole mass spectrometer equipped with an electro-
spray ionization source (ESI) (Waters Corp., Milford, MA).
Label-Free Quantitative Assessment of the Fasted/Re-fed
Hepatic Acetylome
Mice (n=4 in each group) were sacrificed following either an
18 h fast (2030 h–1430 h) or a 13 h fast (2030 h–0930 h) followed
by 5 h re-feeding (0930–1430 h). Proteins were extracted from
harvested livers that were snap frozen and stored in liquid
nitrogen. Around 30 mg of pooled protein/group (7.5 mg from
each mouse) was used for hepatic acetylome analysis. Identifica-
tion and quantification of acetylated proteins was done using
immunoprecipitation followed by liquid chromatography (LC),
MS/MS experiments on a home-built high accuracy mass
spectrometer (Velos FT-ICR) (Weisbrod et al, submitted RCMS).
A detailed description for methodology and calculations can be
found in our recent publication [22].
Hepatic Metabolite Profiling
Freeze clamped liver samples from fasted/re-fed experiments
were extracted in ice-cold methanol/water (1:1) spiked with
internal standards (U-
13C4 succinate and U-
13C6 citric acid, (150 n
moles/gm liver). Lipids were removed by shaking with an equal
volume of chloroform. The aqueous phase was lyophilized,
derivatized [63] and GC/MS analysis performed using an Agilent
7890a GC with a Gerstel automatic liner exchange cooled
injection system CIS 4 PTV injector. Both split and large volume
injections (LVI) of the sample were made. GC/MS conditions and
metabolite identification was done as described [64] using NIST
11 and Fiehn mass spectral libraries.
Lipid Content Analysis
Lipid content analysis (DAGs and TAGs) was performed using
thin layer chromatography as described [65]. Briefly, frozen tissues
(quadriceps, liver) isolated from animals sacrificed at the end of 18 h
fast, 5 h refeeding experiments were weighed, and Bligh-Dryer
extraction for tissue lipid was performed. The extracted lipid was
evaporated under N2 in glass tubes to dryness and re-dissolved in
chloroform:methanol:acetic acid:water (25:15:4:2) normalized by
the weight of the tissue taken to 1 mg/ml solvent. 10 ml (liver) and
50 ml(muscle)ofthe eachsamplewasspottedtotheirrespective lane
on a silica gel plate (Whatman Partisil K6). TLC was then
performed using the conventional three solvent system. An aliquot
of the lipid extract was dried and resuspended in 5% NP-40 solution
and quantified for triglycerides using Triglycerides Reagent kit from
Thermo scientific (cat # TR22203/2750-500).
Determination of Glycogen Content
Frozen tissue (quadriceps, liver) isolated from animals sacrificed
at the end of 18 h fast, 5 h re-feeding experiments were weighed
homogenized in ice-cold 6% perchloric acid. The resultant lysate
was spun at 2000 rpm for 20 minutes and supernatant containing
glycogen was saved. Glycogen was then precipitated with 5
volumes of ice-cold 100% ethanol and left on ice over-night at 4uC
to ensure complete precipitation. The precipitate was collected by
spinning at 5000 rpm/20 minutes. Ethanol precipitation was
repeated one more time to remove any free glucose. The resulting
clean glycogen, was dissolved in 0.1 M sodium acetate buffer
(pH 4.5), and incubated in 50 ml of amyloglucosidase overnight at
37uC. Glycogen hydrolyzed to glucose by the overnight enzyme
reaction was quantitated for glucose colorimetrically using
Quantichrom Glucose assay reagent (cat # DIGL-200).
Immunoblot Analysis
Frozen liver was homogenized in ice-cold lysis buffer (50 mM
Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, 0.25% sodium deoxycho-
late, 1 mM NaF, 1 mM Na3VO4, and 2 mM Na4P2O7)
containing a protease inhibitor mixture (Roche Diagnostics) and
also deacetylase inhibitors for anti-lysine western. The resultant
lysates were centrifuged at 16,0006g for 60 min at 4uC, and
protein concentrations were quantified using the BCA (bicincho-
ninic acid) protein assays (Pierce, Inc.). The protein samples
(30 mg) were separated on an 8% gradient SDS-PAGE gel and
transferred to PVDF membranes using a semidry electroblotter
(BioRad). Membranes were immunoblotted (Antibodies were
purchased from Cell Signalling, Santa Cruz Biotech Inc. and
Immunechem Pharmaceuticals Inc.) and signals were visualized
and quantified using the infrared Odyssey Western Blotting
System (Li-Cor, Lincoln, NE).
Statistical Analyses
Data are expressed as the mean 6 SEM. Analyses for the
significance of differences were performed using the Student’s t-
test and Anova using GraphPad Prism version 5.00 for Windows,
GraphPad Software, San Diego California USA, www.graphpad.
com.
Supporting Information
Figure S1 Immunoblot analysis for fasted/fed expression of key
metabolic proteins. Immunoblot analysis for fasted/fed expression
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GCK, AMPK, ACC involved in hepatic fuel switching showing no
differences in their levels.
(TIF)




2/2 vs. wild-type. The mean and standard deviation
values were calculated under the assumption that the data follow
normal distribution. The top-5% dramatically changed peptides
were determined by those outside mean 6 two-standard deviations.
(TIF)
Figure S3 FAAH deficiency increases fed levels of hepatic and
skeletal muscle triglycerides. Quantification of fed hepatic and
muscle triglycerides in FAAH
2/2 vs. wild-type mice. n=4, data
are mean 6 SEM, **p,0.01 by Student’s t-test.
(TIF)
Figure S4 FAAH deficiency alters fasted/fed hepatic protein
lysine acetylation. a. Global representation of hepatic protein
lysine acetylation by immunopreciptiation and immunoblot
analysis with anti-acetylated lysine antibodies to detect acetylated
proteins in 18 h fasted and 5 h re-fed FAAH
2/2 vs. wild-type
mice (n=4). b. Western analysis on the anti lysine IP for two
different acetylation target proteins (alcohol and malate dehydro-
genase) done as an example to show differential fasting to re-
feeding regulation by acetylation. The flow through from the anti-
lysine immunoprecipitation was used for probing b actin as a
loading control.
(TIF)
Table S1 Summary containing list of total identified acetylated
proteins and acetylated peptides from the hepatic acetylome.
(XLSX)
Table S2 List of largely altered acetylated peptides, their
sequences, protein origins with their index values. In total, 49
acetylated peptides from 12 different proteins that were altered are
presented. Validated peptides with a common sequence but
modifications at different sites are treated as different entries in the
table. An index number was given to each entry. Multiple
acetylated peptides from the same protein were grouped in the list,
so they have neighboring index numbers. @ represents acetylated
lysine residues and $ represents, oxidized methionine residues.
(DOC)
Table S3 Top 5% dramatically changed acetylated peptides
(.4-fold change). The acetylated peptides and corresponding
proteins that showed more than a four-fold change between 18 h
fast/5 h fed FAAH
2/2 and wild-type mice were compared and
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